These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 35640549)

  • 1. Management of Acral and Mucosal Melanoma: Medical Oncology Perspective.
    Jung S; Johnson DB
    Oncologist; 2022 Aug; 27(8):703-710. PubMed ID: 35640549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions.
    Mao L; Qi Z; Zhang L; Guo J; Si L
    Front Immunol; 2021; 12():680407. PubMed ID: 34149718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acral and mucosal melanoma: Current and emerging targeted therapies.
    Zhang J; Tian H; Mao L; Si L
    Crit Rev Oncol Hematol; 2024 Jan; 193():104221. PubMed ID: 38036156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Therapy and Immunotherapy for Melanoma in Japan.
    Namikawa K; Yamazaki N
    Curr Treat Options Oncol; 2019 Jan; 20(1):7. PubMed ID: 30675668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma.
    Klemen ND; Wang M; Rubinstein JC; Olino K; Clune J; Ariyan S; Cha C; Weiss SA; Kluger HM; Sznol M
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32209601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal Melanoma: Epidemiology, Biology and Treatment.
    Spencer KR; Mehnert JM
    Cancer Treat Res; 2016; 167():295-320. PubMed ID: 26601869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable indoleamine 2,3-dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapy.
    Iga N; Otsuka A; Hirata M; Kataoka TR; Irie H; Nakashima C; Matsushita S; Uchi H; Yamamoto Y; Funakoshi T; Fujisawa Y; Yoshino K; Fujimura T; Hata H; Ishida Y; Kabashima K
    Cancer Sci; 2019 Nov; 110(11):3434-3441. PubMed ID: 31509303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoint inhibitor-based therapy for advanced acral and mucosal melanoma.
    Mori T; Izumi T; Doi R; Kamimura A; Takai S; Teramoto Y; Nakamura Y
    Exp Dermatol; 2023 Mar; 32(3):276-289. PubMed ID: 36477933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic characteristics and response to systemic therapies of acral lentiginous melanoma at a tertiary care center-a retrospective review.
    Jamerson T; Rebecca VW; Aguh C
    J Natl Med Assoc; 2022 Feb; 114(1):7-11. PubMed ID: 34509302
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Ponti G; Manfredini M; Greco S; Pellacani G; Depenni R; Tomasi A; Maccaferri M; Cascinu S
    Anticancer Res; 2017 Dec; 37(12):7043-7048. PubMed ID: 29187493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy Options for Acral Melanoma, A fast-growing but Neglected Malignancy.
    Gajón JA; Juarez-Flores A; De León Rodríguez SG; Aguilar Flores C; Mantilla A; Fuentes-Pananá EM; Bonifaz LC
    Arch Med Res; 2022 Dec; 53(8):794-806. PubMed ID: 36460547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Genomic Profiling of Acral Melanoma.
    Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
    J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidisciplinary approach and treatment of acral and mucosal melanoma.
    Fortuna A; Amaral T
    Front Oncol; 2024; 14():1340408. PubMed ID: 38469235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes.
    Wang M; Banik I; Shain AH; Yeh I; Bastian BC
    Genome Med; 2022 Jun; 14(1):65. PubMed ID: 35706047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational pathology, genomics and the development of systemic therapies for acral melanoma.
    Chen YA; Teer JK; Eroglu Z; Wu JY; Koomen JM; Karreth FA; Messina JL; Smalley KSM
    Semin Cancer Biol; 2020 Apr; 61():149-157. PubMed ID: 31689494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advancements in the diagnosis and treatment of acral melanoma.
    Alhaskawi A; Ezzi SHA; Dong Y; Zhou H; Wang Z; Lai J; Yao C; Kota VG; Abdulla MHAH; Lu H
    J Zhejiang Univ Sci B; 2024 Feb; 25(2):106-122. PubMed ID: 38303495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic analysis of melanomas arising in acral sites.
    Zaremba A; Murali R; Jansen P; Möller I; Sucker A; Paschen A; Zimmer L; Livingstone E; Brinker TJ; Hadaschik E; Franklin C; Roesch A; Ugurel S; Schadendorf D; Griewank KG; Cosgarea I
    Eur J Cancer; 2019 Sep; 119():66-76. PubMed ID: 31419753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of anti-PD-1 agents in acral and mucosal melanoma.
    Shoushtari AN; Munhoz RR; Kuk D; Ott PA; Johnson DB; Tsai KK; Rapisuwon S; Eroglu Z; Sullivan RJ; Luke JJ; Gangadhar TC; Salama AK; Clark V; Burias C; Puzanov I; Atkins MB; Algazi AP; Ribas A; Wolchok JD; Postow MA
    Cancer; 2016 Nov; 122(21):3354-3362. PubMed ID: 27533633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma.
    Gui J; Guo Z; Wu D
    J Transl Med; 2022 Aug; 20(1):367. PubMed ID: 35974375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of acral lentiginous melanoma: current updates and future directions.
    Dugan MM; Perez MC; Karapetyan L; Zager JS
    Front Oncol; 2024; 14():1323933. PubMed ID: 38390259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.